The commercialization of the breast cancer movement is challenged in this analysis of how breast cancer has been transformed from a stigmatized disease and individual tragedy to a market-driven industry of survivorship.

Laney Jacobs moves back home to tell the man see loves (and broke his heart) how much he means to her before it's too late.

Explores the hidden costs of the pink ribbon as an industry and analyzes the social impact on women living with breast cancer -- the stereotypes and the stigmas.

It was a tragedy which shook the world. On 1 October 2012, the disappearance of five-year-old April Jones from the mid Wales town of Machynlleth sparked an almost unprecedented wave of concern. Within Wales the event drew people of all ages and backgrounds in their hundreds to help in the search. Further afield social media websites spread the story worldwide and in turn brought messages of hope and support to those directly involved. It demonstrated a community response on an international scale. Today Mark Bridger is serving a life sentence for the horrific murder of April Jones but this book is not about the details of that extreme act of cruelty, it is about the various acts of kindness from within the town and from far outside it. This is book tells the unfolding narrative of April's story over the twelve months since she was taken from her home and her home town, in the words of the people who live there and with the support of April's family. But more than the telling of the tragic events, it tells the story of how people pull together in extreme circumstances; how in today's technological world, community is not about geography alone. It's about strangers coming together. It is a story about hope and humanity. Proceeds from the book will go to the April Jones Fund. The fund set up to aid the search for the missing five-year-old will be divided between local charities, schools, and search and rescue organisations.

A startling and important exposé on the state of medicine, research, and healthcare today by the Chief Medical and Scientific Officer of the American Cancer Society How We Do Harm exposes the underbelly of healthcare today—the overtreatment of the rich, the under treatment of the poor, the financial conflicts of interest that determine the care that physicians' provide, insurance companies that don't demand the best (or even the least expensive) care, and pharmaceutical companies concerned with selling drugs, regardless of whether they improve health or do harm. Dr. Otis Brawley is the chief medical and scientific officer of The American Cancer Society, an oncologist with a dazzling clinical, research, and policy career. How We Do Harm pulls back the curtain on how medicine is really practiced in America. Brawley tells of doctors who select treatment based on payment they will receive, rather than on demonstrated scientific results; hospitals and pharmaceutical companies that seek out patients to treat even if they are not actually ill (but as long as their insurance will pay); a public primed to swallow the latest pill, no matter the cost; and rising healthcare costs for unnecessary—and often unproven—treatments that we all pay for. Brawley calls for rational healthcare, healthcare drawn from results-based, scientifically justifiable treatments, and not just the peddling of hot new drugs. Brawley's personal history – from a childhood in the gang-ridden streets of black Detroit, to the green hallways of Grady Memorial Hospital, the largest public hospital in the U.S., to the boardrooms of The American Cancer Society—results in a passionate view of medicine and the politics of illness in America - and a deep understanding of healthcare today. How We Do Harm is his well-reasoned manifesto for change.

Kate Pickert worked as a health-care journalist and knew medical treatment well, but it all changed when she was diagnosed with an aggressive type of breast cancer at age 35. Pickert used her journalistic skills to identify the cultural, scientific, and historical forces shaping the lives of breast-cancer patients in the modern age.

“Samantha King explains how, beyond being an all-too-frequent and still-too-lethal disease for many women, breast cancer is a corporate dream come true.” —Herizons “Fascinating. King’s deft and thoughtful interpretation of the pink ribbon phenomenon is an important wake-up call. Going against the grain, she takes a clear-eyed look at a trend that often seems to outshine the disease that put it on the map.” —Women’s Review of Books “King’s criticisms of breast-cancer philanthropy provide a new means of looking at one of our culture’s most celebrated causes. For anyone who has ever squirreled away yogurt lids for the cause, Pink Ribbons, Inc. is food for thought.” —Bitch “A fascinating read for anyone whose life has been touched by breast cancer.” —Curve “Breast cancer advocacy is being transformed from meaningful civic participation into purchasing products. To understand the personal, social, and political costs, read this book.” —Barbara Brenner, Executive Director of Breast Cancer Action In Pink Ribbons, Inc., Samantha King traces how breast cancer has been transformed from a stigmatized disease and individual tragedy to a market-driven industry of survivorship. Here, for the first time, King questions the effectiveness and legitimacy of privately funded efforts to stop the epidemic among American women. Highly revelatory-at times shocking-Pink Ribbons, Inc. challenges the commercialization of the breast cancer movement. Samantha King is associate professor of physical and health education and women’s studies at Queen’s University, in Kingston, Ontario